Episode 18: A Between the Biotech Waves conversation with Ram Aiyer, CEO of RNA base editing company Korro Bio
Between the Biotech Waves
00:00
Is There Anything You'd Like to Boost, Optimize Around, Ness?
Having a very good insight into it and having a partner in crime from a scientific perspective to really have the development experience is critical. And I think that I had underestimated what that piece is going to be, especially for a novel technology. It's not just the science, it's lining up the infrastructure and the resources to sort of lay that out over time. Being entirely transparent, transparent as to where we are, I think goes a long way," he said.
Transcript
Play full episode
